arrow_back Back to App

Glioblastoma Awareness Day: Support for Patients and Research

This House of Representatives resolution supports designating July 17, 2024, as Glioblastoma Awareness Day. Its aim is to increase public knowledge about this aggressive brain disease, honor those affected, and encourage further research and development of better treatments. For citizens, this means a greater focus on the needs of glioblastoma patients and potentially faster development of more effective therapies.
Key points
Designation of July 17 as Glioblastoma Awareness Day to increase public knowledge about the disease.
Support for glioblastoma research and the development of new, more effective treatments, offering hope to patients.
Emphasis on the importance of biomarker testing for diagnosis and treatment, potentially improving medical care.
Honoring patients, their families, and caregivers, drawing attention to their challenging situation.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HRES_1203
Sponsor: Rep. Williams, Roger [R-TX-25]
Process start date: 2024-05-06
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Expressing support for the designation of July 17, 2024, as "Glioblastoma Awareness Day".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HRES_1203.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-05-06.

What are the main provisions?

Key points include:

  • Designation of July 17 as Glioblastoma Awareness Day to increase public knowledge about the disease.
  • Support for glioblastoma research and the development of new, more effective treatments, offering hope to patients.
  • Emphasis on the importance of biomarker testing for diagnosis and treatment, potentially improving medical care.
  • Honoring patients, their families, and caregivers, drawing attention to their challenging situation.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Williams, Roger [R-TX-25].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health